Varaico: Literature-Extracted Genetic Variants

Gene:ALPL
Variant:p.T371I
Back to variants list

ALPL

NM_000478.6:p.T371I

Associated Papers

Lipid Metabolism Alterations in Hereditary Inorganic Pyrophosphate Deficiency Syndromes: A Narrative Review of Insights and Controversies.

Derudder R et al.

Journal of Inherited Metabolic Disease, 2026

Vitamin B6 Status in Hypophosphatasia: Association With Clinical Severity, Diagnostic Utility, and Effects on Vitamin B6 Metabolism by Supplementation and Enzyme Replacement Therapy.

Akiyama T et al.

Journal of Inherited Metabolic Disease, 2025

New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry.

Kishnani PS et al.

American Journal of Medical Genetics. Part A, 2024

On pathways and blind alleys-The importance of biomarkers in vitamin B6 -dependent epilepsies.

Plecko B

Journal of Inherited Metabolic Disease, 2023

Dissecting mutational allosteric effects in alkaline phosphatases associated with different Hypophosphatasia phenotypes: An integrative computational investigation.

Xiao F et al.

Plos Computational Biology, 2022

35320273 (PubMed )
Supplement: pcbi.1010009.s009.xlsx › Sheet1

Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia.

Seefried L et al.

Bone, 2021

Lethal Encephalopathy in an Infant with Hypophosphatasia despite Enzyme Replacement Therapy.

Raimann A et al.

Hormone Research in Paediatrics, 2021

Clinical Significance of Hypophosphatasemia in Children.

Bayramli R et al.

Calcified Tissue International, 2020

Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Salles JP

The Clinical Biochemist. Reviews, 2020

Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms.

Fujisawa Y et al.

Frontiers in Endocrinology, 2020

Update on the treatment of vitamin B6 dependent epilepsies.

Mastrangelo M et al.

Expert Review of Neurotherapeutics, 2019

Single suture craniosynostosis: Identification of rare variants in genes associated with syndromic forms.

Clarke CM et al.

American Journal of Medical Genetics. Part A, 2018

Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.

Kishnani PS et al.

Molecular Genetics and Metabolism, 2017

Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.

Whyte MP

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2017

Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

Whyte MP et al.

The Journal of Clinical Endocrinology and Metabolism, 2016

Hypophosphatasia: an overview of the disease and its treatment.

Bianchi ML

Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa, 2015

Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series.

Kosnik-Infinger L et al.

Neurosurgical Focus, 2015

Clinical Forms and Animal Models of Hypophosphatasia.

Salles JP

Sub-cellular Biochemistry, 2015

What Can We Learn About the Neural Functions of TNAP from Studies on Other Organs and Tissues?

Millán JL

Sub-cellular Biochemistry, 2015

Neurological Symptoms of Hypophosphatasia.

Taketani T

Sub-cellular Biochemistry, 2015

Clinical utility gene card for: hypophosphatasia - update 2013.

Mornet E et al.

European Journal of Human Genetics : Ejhg, 2014

Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures.

Belachew D et al.

Jimd Reports, 2013

Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis.

Leung EC et al.

Jimd Reports, 2013

Enzyme-replacement therapy in life-threatening hypophosphatasia.

Whyte MP et al.

The New England Journal of Medicine, 2012

Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5'-phosphate availability.

Balasubramaniam S et al.

Journal of Inherited Metabolic Disease, 2010

Physiological role of alkaline phosphatase explored in hypophosphatasia.

Whyte MP

Annals of the New York Academy of Sciences, 2010

Neurosurgical aspects of childhood hypophosphatasia.

Collmann H et al.

Child's Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery, 2009

Enzyme replacement therapy for murine hypophosphatasia.

Millán JL et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2008

Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.

Baumgartner-Sigl S et al.

Bone, 2007

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."